Primary Record
IB-MECA
- In stock
- 3,889 g
- Purity
- 98.1 %
- CAS
- 152918-18-8
Compound Identifiers & Properties
- CAS
- 152918-18-8
- PubChem CID
- 123683
- SMILES
- CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)NCC4=CC(=CC=C4)I)O)O
- Canonical SMILES
- CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O
Names & Synonyms
- IB-MECA
- piclidenoson
- 3-IB-Meca
- 152918-18-8
- N(6)-Ibamu
- piclidenosonum
- CF-101
- IBMECA
- Cf101
- Piclidenoson [USAN]
- CF 101
- IB MECA
- RefChem:863111
- Piclidenoson (USAN/INN)
- PICLIDENOSON [INN]
- D03VTU
- D0Y6ZK
- UNII-30679UMI0N
- AC1L3X3V
- CHEMBL119709
- 30679UMI0N
- MFCD00671785
- GTPL422
- C18H19IN6O4
- MLS002153391
- PICLIDENOSON [WHO-DD]
- SCHEMBL465039
- DTXSID50165158
- HUJXGQILHAUCCV-MOROJQBDSA-N
- orb1299997
- ALB-7208
- REGID_for_CID_123683
- SCHEMBL29384499
- SCHEMBL29572081
- CHEBI:73286
- CTK8E8477
- N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine
- AOB5361
- SI-615
- GLXC-06152
- HMS2234I04
- HMS3412E09
- HMS3676E09
- RPR-113090
- CF-101; IB-MECA; Piclidenoson
- EX-A2514
- N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide
- ZINC3811810
- BDBM50118812
- C18-H19-I-N6-O4
- CID123683
- N(6)-(3-Iodobenzyl)adenosine-5'-N-methyluronamide
- AKOS024456363
- ACN-038405
- CID:123683
- CS-5048
- DB05511
- NI10756
- IB-MECA, solid, >=98% (HPLC)
- 3-iodobenzyl-5'-N-methylcarboxamidoadenosine
- NCGC00024978-02
- NCGC00024978-03
- NCGC00024978-04
- NCGC00024978-05
- NCGC00024978-09
- AC-36111
- AN-16662
- AS-16876
- DA-74381
- HY-13591
- SC-41757
- SID:53789321
- SMR001230772
- SY012528
- SID:135653740
- J584.717F
- LS-184434
- RT-013304
- NS00069256
- 1-Deoxy-1-(6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-N-methyl-beta-D-ribofuranuronamide
- D10971
- N(6)-(3-iodo-benzyl)adenosine-5'-N-methyluronamide
- (2S,3S,4R,5R)-3,4-dihydroxy-5-(6-((3-iodobenzyl)amino)-9H-purin-9-yl)-N-methyltetrahydrofuran-2-carboxamide
- (2S,3S,4R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]purin-9-yl]-N-methyloxolane-2-carboxamide
- A848868
- C084956
- C478920
- 3-(2-Methoxybenzyl)pyrrolidine ethanedioate (1:1)
- N6-(3-iodobenzyl)-5''-N-methylcarboxamidoadenosine
- (N-6-(3-iodobenzyl)adenosine-5''-N-methyluronamide
- BRD-K31135544-001-07-0
- Q27088384
- N(6)-(3-Iodobenzyl)-5'-N-methylcarboxamido adenosine
- B2693-256549
- beta-D-Ribofuranuronamide, 1-deoxy-1-(6-(((3-iodophenyl)methyl)amo)-9H-purin-9-yl)-N-methyl-
- (2S,3S,4R,5R)-3,4-dihydroxy-5-(6-(3-iodobenzylamino)-9H-purin-9-yl)-N-methyltetrahydrofuran-2-carboxamide
- Methyl 1-(N6-(3-iodobenzyl)-adenin-9-yl)-b-D-ribofuronamide
- 5 -Methylamino-N-(3-iodobenzyl)-5 -oxo-5 -deoxyadenosine
- (2S,3S,4R,5R)-3,4-dihydroxy-5-(6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-N-methyloxolane-2-carboxamide
- (2S,3S,4R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]purin-9-yl]-N-methyl-tetrahydrofuran-2-carboxamide
- (2S,3S,4R,5R)-5-{6-[(3-iodobenzyl)amino]-9H-purin-9-yl}-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide
- Adenosine, N(6)-[3-iodobenzyl]-4'-methylcarbamoyl-4'-dehydroxymethyl-
- N-(3-Iodobenzyl)-5 -deoxy-5 -oxo-5 -(methylamino)adenosine
- N-(3-Iodobenzyl)-5 -oxo-5 -(methylamino)-5 -deoxyadenosine
- N6-(3-Iodobenzyl)adenosine-5 inverted exclamation marka-N-methyluronamide
- 1-deoxy-1-(6-(((iodophenyl)methyl)amino)9H-purine-9-yl)-N-methyl-(D-ribofuranuronamide)
- 1-Deoxy-1-[6-[((3-iodophenyl)methyl)amino]-9H-purin-9-yl]-N-methyl-?-D-ribofuranuronamide
- 1-Deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-?-D-ribofuranuronamide
- (2R,3R,4S,5S)-5-(6-(3-iodobenzylamino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide;CF 101
- (2S,3S,4R,5R)-3,4-dihydroxy-5-(6-((3-iodophenyl)methylamino)purin-9-yl)-N-methyloxolane-2-carboxamide
- (2S,3S,4R,5R)-3,4-dihydroxy-5-(6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-N-methyloxolane-2-carboxamide (non-preferred name)
- (2S,3S,4R,5R)-3,4-Dihydroxy-5-[6-(3-iodo-benzylamino)-purin-9-yl]-tetrahydro-furan-2-carboxylic acid methylamide
- (2S,3S,4R,5R)-3,4-Dihydroxy-5-[6-(3-iodobenzylamino)-9H-purin-9-yl]-N-methyltetrahydrofuran-2-carboxamide
- (2S,3S,4R,5R)-5-(6-(3-iodobenzylamino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide
- (3R,4S,5R)-3,4-Dihydroxy-5-[6-(3-iodo-benzylamino)-purin-9-yl]-tetrahydro-furan-2-carboxylic acid methylamide
- (3S,4R,5R)-3,4-Dihydroxy-5-[6-(3-iodo-benzylamino)-purin-9-yl]-tetrahydro-furan-2-carboxylic acid methylamide
- .BETA.-D-RIBOFURANURONAMIDE, 1-DEOXY-1-(6-(((3-IODOPHENYL)METHYL)AMINO)-9H-PURIN-9-YL)-N-METHYL-
- 1-Deoxy-1-[6-[((3-Iodophenyl)methyl)amino]-9H-purin-9-yl]-N-methyl-|A-D-ribofuranuronamide
- 1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9h-purin-9-yl]-n-methyl-beta-d-ribofuranuronamide
- 1170381-63-1
- 1beta-[6-[(3-Iodobenzyl)amino]-9H-purine-9-yl]-5-oxo-5-(methylamino)-1,5-dideoxy-beta-D-ribofuranose
- 3,4-Dihydroxy-5-[6-(3-iodo-benzylamino)-purin-9-yl]-tetrahydro-furan-2-carboxylic acid methylamide
- b-D-Ribofuranuronamide,1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-
- Q8L